VOLZ, H. P., Eliška BARTEČKŮ, Lucie BARTOVA, J. BESSA, D. DE BERARDIS, J. DRAGASEK, H. KOZHUHAROV, M. LADEA, J. LAZÁRY, M. ROCA, G. USOV, A. WICHNIAK, B. GODMAN a S. KASPER. Sick leave duration as a potential marker of functionality and disease severity in depression. International Journal of Psychiatry in Clinical Practice. Oxon: TAYLOR & FRANCIS LTD, 2022, roč. 26, č. 4, s. 406-416. ISSN 1365-1501. Dostupné z: https://dx.doi.org/10.1080/13651501.2022.2054350.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Sick leave duration as a potential marker of functionality and disease severity in depression
Autoři VOLZ, H. P. (garant), Eliška BARTEČKŮ (203 Česká republika, domácí), Lucie BARTOVA (203 Česká republika), J. BESSA, D. DE BERARDIS, J. DRAGASEK, H. KOZHUHAROV, M. LADEA, J. LAZÁRY, M. ROCA, G. USOV, A. WICHNIAK, B. GODMAN a S. KASPER.
Vydání International Journal of Psychiatry in Clinical Practice, Oxon, TAYLOR & FRANCIS LTD, 2022, 1365-1501.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30215 Psychiatry
Stát vydavatele Velká Británie a Severní Irsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 3.000
Kód RIV RIV/00216224:14110/22:00126851
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1080/13651501.2022.2054350
UT WoS 000777522800001
Klíčová slova anglicky Absenteeism; depression; functionality; major depressive disorder; return to work; sick leave
Štítky 14110222, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 16. 1. 2023 13:57.
Anotace
Objective: To discuss the impact of depression on work and how depression-related sick leave duration could be a potential indicator and outcome for measuring functionality in depression. Methods: Our review was based on a literature search and expert opinion that emerged during a virtual meeting of European psychiatrists that was convened to discuss this topic. Results: Current evidence demonstrates that depression-related sick leave duration is influenced by multiple disease-, patient- and work-related factors, together with societal attitudes towards depression and socioeconomic conditions. A wide variety of pharmacological and non-pharmacological treatments and work-based interventions are effective in reducing depression-related sick leave duration and/or facilitating return to work. Recent real-world evidence showed that patients treated with antidepressant monotherapy appear to recover their working life faster than those receiving combination therapy. Although depression-related sick leave duration was found to correlate with severity of depressive symptoms, it cannot be used alone as a viable marker for disease severity. Conclusions: Given its multifactorial nature, depression-related sick leave duration is not on its own a viable outcome measure of depression severity but could be used as a secondary outcome alongside more formal severity measures and may also represent a useful measure of functionality in depression.
VytisknoutZobrazeno: 30. 5. 2024 06:50